Skip to main content

Table 5 Changes in breast cancer subtype between primary breast tumors and matched recurrent lesions

From: Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis

Subtype/primary

No. of cases

Recurrent lesions

Discordance %

  

Luminal A

Luminal B

HER2

TN

 

Luminal A

57

41 (71.2)

8 (14.0)

1 (1.8)

7 (12.3)

28.8

Luminal B

6

2 (33.3)

4 (66.7)

  

33.3

HER2

16

0

2 (12.5)

13 (81.3)

1 (6.3)

18.7

TN

18

1 (5.6)

0

2 (11.1)

15 (83.3)

16.7

Total

97

44

14

16

23

24.7

  1. TN: Triple Negative